Cargando…
Evolving treatment landscape for early and advanced pancreatic cancer
Pancreatic ductal adenocarcinoma is an infrequent cancer with a high disease related mortality rate, even in the context of early stage disease. Until recently, the rate of death from pancreatic cancer has remained largely similar whereby gemcitabine monotherapy was the mainstay of systemic treatmen...
Autores principales: | Lau, Sally C, Cheung, Winson Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534396/ https://www.ncbi.nlm.nih.gov/pubmed/28808501 http://dx.doi.org/10.4251/wjgo.v9.i7.281 |
Ejemplares similares
-
A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma
por: Yu, Irene S., et al.
Publicado: (2018) -
The evolving immunotherapeutic landscape in advanced oesophagogastric
cancer
por: Flynn, Michael, et al.
Publicado: (2018) -
The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015) -
Gastric cancer: current and evolving treatment landscape
por: Sun, Weijing, et al.
Publicado: (2016) -
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)